Shannon Grant

机构：Fred Hutch Cancer Center · ORCID：0000-0002-7297-8070

发表论文 39 篇 · 总被引 799 次 · h-index 15

代表论文

• Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial (2018 · The Lancet HIV · 被引 125)
• Discontinuation of Biologic Therapy in Rheumatoid Arthritis: Analysis from the Corrona RA Registry (2017 · Rheumatology and Therapy · 被引 66)
• Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial (2019 · The Lancet HIV · 被引 50)
• Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines (2020 · PLoS Medicine · 被引 48)
• Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial (2025 · Science Translational Medicine · 被引 44)
• Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial (2018 · The Journal of Infectious Diseases · 被引 44)